Blog

Dec 27, 2013

Drug Hopes to Delay Onset of Alzheimer’s Symptoms With a Monthly Shot in the Arm

Posted by in categories: biotech/medical, medical

PET_scan-normal_brain-alzheimers_disease_brain-banner

Alzheimer’s disease is on the rise, even as doctors continue to struggle to find potential treatments for it. Researchers expect the number of those suffering from dementia to grow from 44 million at present to three times that by 2050.

The growing number puts increased pressure on researchers to do something to ameliorate the disease. And one drug is attracting the spotlight as it enters clinical trials. Eric Karran, the director of research at Alzheimer’s Research UK, said in a press conference in the lead-up to a G8 summit on dementia that he is “full of hope” that a drug now being tested in the United States on patients with mild dementia may be to Alzheimer’s disease what statins are to heart disease.

Read more

Comments are closed.